Genetics for docs

Silicon Valley Biosystems Corp. is developing genomic-based algorithms it says will provide "precise actionable" diagnostic results to clinicians at the bedside. The company, which made its debut last week, has undisclosed funding from Sequoia Capital.

According to President and CEO Dietrich Stephan, the company can stand out in the increasingly crowded genomics space because its product is tailored to provide diagnostic-grade genomic information in a clinician-friendly format...